The suboptimal performance of MMP-9 was also evidenced by Mroczko et al. (2010)21 reporting a 55% sensitivity for CRC, and more recently by Pengjun et al. (2013)26 that do not include this metalloproteinase in their serum panel for the detection of CRC. This evidence concerns the gene MMP9 and colorectal carcinoma.